Jefferies Initiates Coverage On Nuvalent with Buy Rating, Announces Price Target of $97
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Roger Song initiates coverage on Nuvalent (NASDAQ:NUVL) with a Buy rating and a price target of $97.

April 17, 2024 | 11:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies initiated coverage on Nuvalent with a Buy rating and set a price target of $97.
The initiation of coverage by Jefferies with a Buy rating and a high price target of $97 is likely to generate positive sentiment among investors, potentially driving up the stock price in the short term. Analyst ratings, especially from reputable firms like Jefferies, can significantly influence investor perception and stock performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100